A federal judge issued a preliminary injunction against a new government pilot set to significantly shift how certain ...

Court blocks US gov's 340B Rebate Model Pilot Program, citing failure to meet admin law reqs. Hospital groups argued for ...

A federal judge granted a temporary restraining order blocking the Department of Health and Human Services from launching its 340B Rebate Model Pilot Program, which was scheduled to begin Jan. 1, 2026 ...

Judge Lance Walker sided with the American Hospital Association (AHA) and other plaintiffs in the lawsuit, brought in a Maine ...

The Trump administration is temporarily barred from launching its 340B Rebate Model Pilot Program on Jan. 1, 2026, a federal judge ruled. The program would change the upfront drug discount model with ...

As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it.

Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...

A federal judge in Maine has put the brakes on a pilot program that would have enabled biopharma companies to offer rebates instead of up-front discounts as part of the 340B program beginning Jan. 1, ...

The past year has seen a great deal of controversy surrounding the 340B Drug Pricing Program, in which drug manufacturers make prescription drugs available to safety net healthcare providers at deeply ...

This program’s importance is something the senator understands well from his visits to nearly every single hospital in the state. Topeka Capital-Journal file photo The purpose of the U.S. Senate’s ...

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) commended the Biden administration for holding shameless, greedy drug companies accountable for illegally denying price discounts on ...

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) condemns the latest series of attempts by drug manufacturers to undermine an essential part of the healthcare safety net, the 340B Drug ...